Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332:617-618 (18 March), doi:10.1136/bmj.332.7542.617
Does Rose's population prevention axiom still apply in the 21st century?
| The first 150 words of the full text of this article appear below. |
In this issue (p 659) Manuel and colleagues report how they estimated the effectiveness of three strategies to lower blood cholesterol concentrations in Canadians adults.1 A "population" strategy assumed that blood cholesterol could be lowered by 2% in the whole population and deaths from coronary heart disease by 2.7%. The two other strategies were patient based, assuming that prescribing statins to subgroups of people at high risk of coronary heart disease would reduce their risk by 27%. A "single risk factor" strategy targeted patients with blood cholesterol levels greater than 6.2 mmol/l and a "baseline risk" strategy targeted those with a baseline risk of cardiovascular disease greater than 15% over five years, irrespective of their blood cholesterol levels.
Surprisingly, the population strategy, based on the axiom by British epidemiologist Geoffrey Rose that "a large number of people at small risk may give rise to more cases than
Rod Jackson, professor
Section of Epidemiology and Biostatistics, School of Population Health, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland, New Zealand
(rt.jackson@auckland.ac.nz)
John Lynch, professor, Sam Harper, research fellow
Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada H3A 1A2
Read all Rapid Responses
What can you learn from this BMJ paper? Read Leanne Tite's Paper+